NO904430L - Fremgangsmaate for fremstilling av fibrinogenreseptor-antagonister. - Google Patents

Fremgangsmaate for fremstilling av fibrinogenreseptor-antagonister.

Info

Publication number
NO904430L
NO904430L NO90904430A NO904430A NO904430L NO 904430 L NO904430 L NO 904430L NO 90904430 A NO90904430 A NO 90904430A NO 904430 A NO904430 A NO 904430A NO 904430 L NO904430 L NO 904430L
Authority
NO
Norway
Prior art keywords
fibrinogene
procedure
preparation
receptor antagonists
chem
Prior art date
Application number
NO90904430A
Other languages
English (en)
Norwegian (no)
Other versions
NO904430D0 (no
Inventor
Ruth F Nutt
Daniel F Veber
Stephen F Brady
Mark E Duggan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO904430D0 publication Critical patent/NO904430D0/no
Publication of NO904430L publication Critical patent/NO904430L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO90904430A 1989-10-13 1990-10-12 Fremgangsmaate for fremstilling av fibrinogenreseptor-antagonister. NO904430L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42104989A 1989-10-13 1989-10-13

Publications (2)

Publication Number Publication Date
NO904430D0 NO904430D0 (no) 1990-10-12
NO904430L true NO904430L (no) 1991-04-15

Family

ID=23668978

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90904430A NO904430L (no) 1989-10-13 1990-10-12 Fremgangsmaate for fremstilling av fibrinogenreseptor-antagonister.

Country Status (17)

Country Link
US (1) US5374622A (fr)
EP (1) EP0422937B1 (fr)
JP (1) JP2559289B2 (fr)
KR (1) KR910007958A (fr)
AT (1) ATE102219T1 (fr)
AU (1) AU644380B2 (fr)
CA (1) CA2027314A1 (fr)
DE (1) DE69007004T2 (fr)
DK (1) DK0422937T3 (fr)
ES (1) ES2062400T3 (fr)
FI (1) FI905023A0 (fr)
IE (1) IE66253B1 (fr)
IL (1) IL95918A0 (fr)
NO (1) NO904430L (fr)
NZ (1) NZ235564A (fr)
PT (1) PT95581A (fr)
ZA (1) ZA908159B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686566A (en) * 1989-06-16 1997-11-11 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5795867A (en) * 1989-06-16 1998-08-18 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5643872A (en) * 1989-10-23 1997-07-01 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
US6019958A (en) * 1991-02-08 2000-02-01 Diatide, Inc. Technetium-99m labeled peptides for imaging inflammation
US5830856A (en) * 1991-02-08 1998-11-03 Diatide, Inc. Radiolabeled compounds for thrombus imaging
US5645815A (en) * 1991-02-08 1997-07-08 Diatide, Inc. Radiolabled compounds for thrombus imaging
US5736122A (en) * 1991-02-08 1998-04-07 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
DK0570493T3 (da) * 1991-02-08 2000-06-26 Diatide Inc Technetium-99m-mærkede polypeptider til billeddannelse.
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US6107459A (en) * 1991-02-08 2000-08-22 Diatide, Inc. Technetium-99m labeled peptides for diagnostic imaging
US5635477A (en) * 1991-09-30 1997-06-03 The Dupont Merck Pharmaceutical Company Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
IL103252A (en) 1991-09-30 1997-03-18 Du Pont Merck Pharma CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US5250679A (en) * 1991-10-18 1993-10-05 Genentech, Inc. Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
US5674865A (en) * 1991-10-18 1997-10-07 Genentech, Inc. Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa
EP0667783B1 (fr) * 1991-11-07 1999-04-21 The University Of Southern California Compositions et procedes permettant d'eviter la formation d'adherences
US5968476A (en) * 1992-05-21 1999-10-19 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
US5338725A (en) * 1992-06-30 1994-08-16 The Research Foundation Of The State University Of New York Anti-aggregatory agents for platelets
DK0665853T3 (da) * 1992-10-02 2002-11-04 Diatide Inc Multimere polyvalente antitrombotiske midler
EP0672059A1 (fr) * 1992-11-18 1995-09-20 The Du Pont Merck Pharmaceutical Company COMPOSES CYCLIQUES LIES PAR UN NOYAU HETEROCYCLIQUE UTILISES EN TANT QU'INHIBITEURS DE LA GLYCOPROTEINE IIb/IIIa PLAQUETTAIRE
CA2159072A1 (fr) * 1993-03-29 1994-10-13 Lin-Hua Zhang Nouveaux procedes et composes intermediaires utilises pour la preparation d'inhibiteurs iib/iiia de glycoproteines de plaquettes
WO1994023758A1 (fr) * 1993-04-08 1994-10-27 Diatech, Inc. Composes marques isotopiquement utiles pour visualiser les thrombus
US5646000A (en) * 1994-09-29 1997-07-08 Merck & Co., Inc. Compounds and methods for identifying activated platelets
US5858972A (en) * 1996-01-11 1999-01-12 La Jolla Cancer Research Foundation Antithrombotic agents and methods of use
US6623981B2 (en) * 1998-01-27 2003-09-23 Bristol-Myers Squibb Company Detection of patients at risk for developing integrin antagonist/agonist mediated disease states
EA003101B1 (ru) 1998-03-19 2002-12-26 Бристол-Майерз Сквибб Компани Двухфазная система доставки с регулируемым высвобождением для фармацевтических средств с высокой растворимостью и способ лечения диабета с помощью этой системы
CA2328234C (fr) 1998-04-16 2009-03-17 Texas Biotechnology Corporation Composes inhibant la fixation d'integrines a leurs recepteurs
US6808698B1 (en) 1999-03-26 2004-10-26 Bristol-Myers Squibb Pharma Company Method for localization of blood clots
US6685914B1 (en) 1999-09-13 2004-02-03 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
US7319149B2 (en) 2003-06-13 2008-01-15 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
US7317104B2 (en) 2003-06-13 2008-01-08 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
CN107080846A (zh) 2010-07-09 2017-08-22 詹姆斯.特林卡.格林 用于包括瑞格列净的短半衰期药物的组合立即/延迟释放递送系统

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5921656A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd ポリペプチド誘導体
GB8305985D0 (en) * 1983-03-04 1983-04-07 Szelke M Enzyme inhibition
US4988621A (en) * 1985-05-24 1991-01-29 La Jolla Cancer Research Foundation Peptides in cell detachment and aggregation
CA1311583C (fr) * 1986-12-15 1992-12-15 Gerard Armand Marguerie De Rotrou Derives peptides et leur application, surtout en therapie
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
WO1989005150A1 (fr) * 1987-12-10 1989-06-15 La Jolla Cancer Research Foundation Peptides d'adhesion cellulaire a stabilisation conformationnelle
ZW6189A1 (en) * 1988-05-09 1990-05-09 Smithkline Beckman Corp Anti-aggregatory peptides
JP2945680B2 (ja) * 1988-09-09 1999-09-06 旭硝子株式会社 ペプチド誘導体およびその用途
CA2008116C (fr) * 1989-02-23 2001-11-20 Thomas Weller Derives de glycine
US4952562A (en) * 1989-09-29 1990-08-28 Rorer Pharmaceutical Corporation Anti-thrombotic peptides and pseudopeptides
NZ235563A (en) * 1989-10-13 1993-04-28 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical composition
CA2027936C (fr) * 1989-10-23 2001-07-24 Smithkline Beecham Corporation Peptides cycliques anti-agregants

Also Published As

Publication number Publication date
EP0422937A1 (fr) 1991-04-17
KR910007958A (ko) 1991-05-30
ATE102219T1 (de) 1994-03-15
EP0422937B1 (fr) 1994-03-02
DE69007004T2 (de) 1994-10-06
FI905023A0 (fi) 1990-10-12
US5374622A (en) 1994-12-20
PT95581A (pt) 1991-09-13
AU6456890A (en) 1991-04-18
IE903629A1 (en) 1991-04-24
IE66253B1 (en) 1995-12-27
NO904430D0 (no) 1990-10-12
DK0422937T3 (da) 1994-03-28
JP2559289B2 (ja) 1996-12-04
JPH03206097A (ja) 1991-09-09
ZA908159B (en) 1991-07-31
CA2027314A1 (fr) 1991-04-14
NZ235564A (en) 1993-10-26
AU644380B2 (en) 1993-12-09
ES2062400T3 (es) 1994-12-16
DE69007004D1 (de) 1994-04-07
IL95918A0 (en) 1991-07-18

Similar Documents

Publication Publication Date Title
NO904430D0 (no) Fremgangsmaate for fremstilling av fibrinogenreseptor-antagonister.
NO904431D0 (no) Fremgangsmaate for fremstilling av fibrinogenreseptor-antagonister.
ES2070660B1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
ES2061733T3 (es) Nuevos derivados peptidicos inhibidores de la agregacion de plaquetas.
DE69013750D1 (de) Antagonisten von excitatorischen Aminosäuren.
ES2055024T3 (es) Derivados de acido l-glutamico.
ATE115579T1 (de) Imidazolsulfonamid-derivate, herbizide und verfahren zur bekämpfung von schadpflanzen.
ES2104688T3 (es) Un procedimiento para la preparacion de un compuesto de tio-3-cefem 3-sustituido.
ES2053579T3 (es) Nuevas fenilureas.
DE69007331D1 (de) Antirhinovirale Pyridazinamine.
ATE114309T1 (de) N-azabicyclo(3.3.0>octanamide von aromatischen säuren.
DE69020752D1 (de) Peptide, die eine reninhemmende Aktivität besitzen, deren Herstellung und Verwendung.
ATE110385T1 (de) Derivate von aminocarboxylsäure.
DE68914950D1 (de) Aminsalze von 1,4,2-Oxazaphospholidin-2-alkoxy-2-oxid-4-essigsäuren.
DK661388D0 (da) Fremgangsmaade til fremstilling af thiophenforbindelser